Home/Filings/4/0000899243-22-032038
4//SEC Filing

Pillar Invest Corp 4

Accession 0000899243-22-032038

CIK 0000861838other

Filed

Sep 25, 8:00 PM ET

Accepted

Sep 26, 4:32 PM ET

Size

17.8 KB

Accession

0000899243-22-032038

Insider Transaction Report

Form 4
Period: 2022-09-22
Transactions
  • Exercise of In-Money

    Common Stock

    2022-09-22$0.01/sh+1,533,159$15,3327,266,954 total(indirect: By Foundation)
  • Exercise of In-Money

    Prefunded Warrants

    2022-09-221,533,1591,533,159 total(indirect: By Foundation)
    Exercise: $0.01From: 2020-12-11Common Stock (1,533,159 underlying)
Holdings
  • Common Stock

    (indirect: By Abude Umari See Footnote)
    386,110
  • Common Stock

    (indirect: By Pillar Pharmaceuticals 6, L.P. See Footnote)
    2,304,180
  • Common Stock

    (indirect: By Youssef El Zein See Footnote)
    26,308
Umari Abude
10% Owner
Transactions
  • Exercise of In-Money

    Prefunded Warrants

    2022-09-221,533,1591,533,159 total(indirect: By Foundation)
    Exercise: $0.01From: 2020-12-11Common Stock (1,533,159 underlying)
  • Exercise of In-Money

    Common Stock

    2022-09-22$0.01/sh+1,533,159$15,3327,266,954 total(indirect: By Foundation)
Holdings
  • Common Stock

    (indirect: By Abude Umari See Footnote)
    386,110
  • Common Stock

    (indirect: By Youssef El Zein See Footnote)
    26,308
  • Common Stock

    (indirect: By Pillar Pharmaceuticals 6, L.P. See Footnote)
    2,304,180
Transactions
  • Exercise of In-Money

    Common Stock

    2022-09-22$0.01/sh+1,533,159$15,3327,266,954 total(indirect: By Foundation)
  • Exercise of In-Money

    Prefunded Warrants

    2022-09-221,533,1591,533,159 total(indirect: By Foundation)
    Exercise: $0.01From: 2020-12-11Common Stock (1,533,159 underlying)
Holdings
  • Common Stock

    (indirect: By Abude Umari See Footnote)
    386,110
  • Common Stock

    (indirect: By Pillar Pharmaceuticals 6, L.P. See Footnote)
    2,304,180
  • Common Stock

    (indirect: By Youssef El Zein See Footnote)
    26,308
Transactions
  • Exercise of In-Money

    Common Stock

    2022-09-22$0.01/sh+1,533,159$15,3327,266,954 total(indirect: By Foundation)
  • Exercise of In-Money

    Prefunded Warrants

    2022-09-221,533,1591,533,159 total(indirect: By Foundation)
    Exercise: $0.01From: 2020-12-11Common Stock (1,533,159 underlying)
Holdings
  • Common Stock

    (indirect: By Abude Umari See Footnote)
    386,110
  • Common Stock

    (indirect: By Youssef El Zein See Footnote)
    26,308
  • Common Stock

    (indirect: By Pillar Pharmaceuticals 6, L.P. See Footnote)
    2,304,180
Pillar Invest Corp
Director10% Owner
Transactions
  • Exercise of In-Money

    Prefunded Warrants

    2022-09-221,533,1591,533,159 total(indirect: By Foundation)
    Exercise: $0.01From: 2020-12-11Common Stock (1,533,159 underlying)
  • Exercise of In-Money

    Common Stock

    2022-09-22$0.01/sh+1,533,159$15,3327,266,954 total(indirect: By Foundation)
Holdings
  • Common Stock

    (indirect: By Abude Umari See Footnote)
    386,110
  • Common Stock

    (indirect: By Pillar Pharmaceuticals 6, L.P. See Footnote)
    2,304,180
  • Common Stock

    (indirect: By Youssef El Zein See Footnote)
    26,308
Footnotes (3)
  • [F1]Pillar Invest Corporation ("Pillar GP") is the general partner of Pillar Pharmaceuticals 6, L.P. ("Pillar 6") and Pillar Partners Foundation, L.P. ("Pillar Partners", together with Pillar GP and Pillar 6, the "Pillar Funds"). Youssef El Zein and Abude Umari are directors of Pillar GP. Each of Pillar GP, Mr. El Zein and Mr. Umari disclaims Section 16 beneficial ownership of the securities beneficially owned by the Pillar Funds and this report shall not be deemed an admission that any of Pillar GP, Mr. El Zein or Mr. Umari is the Section 16 beneficial owner of any such securities, except to the extent of its or his pecuniary interest therein, if any, by virtue of its or his ownership interest in the Pillar Funds or Pillar GP, as applicable.
  • [F2]1,533,159 of such warrants beneficially owned and exercised for shares of common stock by Pillar Partners, of which Pillar GP is the general partner (the "Pillar Partners Warrants"). Pillar GP disclaims Section 16 beneficial ownership of the Pillar Partners Warrants and the common stock underlying such warrants and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar Partners Warrants.
  • [F3]The Pre-funded Warrants have no expiration date.

Issuer

IDERA PHARMACEUTICALS, INC.

CIK 0000861838

Entity typeother
IncorporatedCayman Islands

Related Parties

1
  • filerCIK 0001534428

Filing Metadata

Form type
4
Filed
Sep 25, 8:00 PM ET
Accepted
Sep 26, 4:32 PM ET
Size
17.8 KB